Lustfeld et al. suggested that an elevated percentage of CD4+ T-cells amid residual BM T-cells in ALL is associated with a favorable prognosis for early hematological remission and in turn affects the final prognosis [1]. This evidence concerns the gene CD4 and acute lymphoblastic leukemia.